What Is the Pregnenolone Blood Test?

A pregnenolone blood test measures the concentration of pregnenolone, a steroid hormone, circulating in your bloodstream. It is most commonly ordered to help evaluate suspected disorders of the adrenal glands or to investigate unusual patterns in steroid hormone production. Because pregnenolone sits at the very top of the steroid hormone family tree, serving as the raw material from which your body builds cortisol, testosterone, estrogen, and many other hormones, its levels can reveal problems that ripple through multiple hormonal pathways at once.

Why Pregnenolone Matters in Hormone Production

Every steroid hormone your body makes traces back to cholesterol. An enzyme called CYP11A1, located on the inner membrane of mitochondria, clips a piece off cholesterol and converts it into pregnenolone. That single conversion is the rate-limiting first step of all steroid hormone synthesis.¹ From there, pregnenolone branches into two major pathways: one leads toward cortisol and aldosterone (the hormones that manage stress and blood pressure), and the other leads toward DHEA, testosterone, and estrogen (the sex hormones). A blood test that catches an abnormality in pregnenolone can therefore point to a bottleneck or overproduction that affects an entire cascade of downstream hormones.

When Doctors Order the Test

Pregnenolone is not part of routine blood work. It tends to be ordered in specific clinical situations where standard hormone panels have turned up something unusual or where a particular diagnosis is suspected. The most common reasons include:

Congenital adrenal hyperplasia (CAH): Certain enzyme deficiencies cause pregnenolone or its close derivative 17-hydroxypregnenolone to accumulate because the next step in the pathway is blocked. In newborns and infants, elevated pregnenolone and 17-hydroxypregnenolone are marker steroids for diagnosing the 3β-hydroxysteroid dehydrogenase deficiency form of CAH.²
Adrenocortical carcinoma (ACC): Tumors of the adrenal cortex often overproduce steroid precursors. A prospective study found that concentrations of 17-hydroxypregnenolone, 17-hydroxyprogesterone, and 11-deoxycortisol were three to ten times higher in patients with adrenocortical carcinoma compared to those with non-cancerous adrenal masses.³ A pregnenolone blood test, often ordered alongside a broader steroid panel, helps distinguish these tumors from benign adrenal growths.
Adrenal insufficiency workup: When the adrenals are underperforming, looking at precursors like pregnenolone alongside cortisol and DHEA can help clarify where in the production chain the problem lies.
Monitoring supplementation: Pregnenolone supplements are sold over the counter in some countries, and clinicians researching their effects or prescribing them off-label may order blood tests to track circulating levels.

What Can Shift Your Levels Before the Draw

Pregnenolone is not a static number. Several factors can move it around enough to affect what the test shows, and understanding these helps you (and your doctor) interpret the result correctly.

Time of Day

Like cortisol, pregnenolone follows a circadian rhythm. Levels tend to be highest in the morning and taper off later in the day. In women, this daily rhythm is most clearly detectable during the early follicular phase of the menstrual cycle but becomes masked by rising ovarian production during the luteal phase.⁴ That means a morning blood draw and an afternoon blood draw could give meaningfully different numbers, especially in premenopausal women during the first half of their cycle.

Menstrual Cycle Phase, Menopause, and Oral Contraceptives

Pregnenolone rises across the menstrual cycle: levels are lowest during the follicular phase, climb during the periovulatory period, and climb further during the luteal phase.⁴ Menopause, oral contraceptive use, and body mass index can also move several adrenal steroid concentrations around in ways that matter for interpretation.⁵ If your doctor is ordering a pregnenolone test, let them know where you are in your cycle, whether you take hormonal birth control, and any other hormonal medications you use.

Sleep and Shift Work

Because steroid hormone production is tied to your internal clock, disruptions to your sleep-wake cycle can affect pregnenolone levels. A study comparing shift workers to daytime workers found that shift workers had lower serum pregnenolone (and lower total testosterone) than their day-shift counterparts.⁶ If you work nights or rotating shifts, mention this when discussing your results.

How the Sample Is Handled Matters

One underappreciated wrinkle with pregnenolone testing is that the sample itself is somewhat fragile. A real-world study examining pre-analytical stability found that pregnenolone levels in plasma began to drop within an hour of the blood being drawn. Pregnenolone also became unstable when stored at refrigerator temperature after centrifugation, while many other steroid hormones held steady for longer.⁷ This means the lab’s handling speed and storage conditions can influence accuracy. If your result seems inconsistent with your clinical picture, your doctor may want to retest with tighter sample-handling protocols.

Immunoassay Versus Mass Spectrometry

Two main technologies measure steroid hormones in blood. Traditional immunoassays use antibodies that bind to the target hormone, but the problem is that pregnenolone is structurally similar to several of its metabolites. Those look-alikes can cross-react with the antibodies and inflate or distort the reading. Mass spectrometry-based methods are more precise: they separate hormones by molecular weight and structure, which largely eliminates cross-reactivity problems. These newer platforms also allow labs to measure multiple steroids from a single blood sample, which is especially useful when doctors want a full steroid profile rather than just one number.⁸

If your test was run using an older immunoassay method, the result may be less reliable than one run on a mass spectrometry platform. Some labs report the method used; if yours does not, it is reasonable to ask. This is especially relevant when the test is being used for diagnosis (as in CAH screening or adrenal tumor workup), where the difference between “slightly elevated” and “clearly abnormal” can drive important clinical decisions.

Pregnenolone Testing in Newborns and Infants

Pregnenolone levels in newborns are very different from those in adults, and they change rapidly over the first days and weeks of life. A longitudinal study of full-term and preterm neonates aimed to establish normative data for pregnenolone and 17-hydroxypregnenolone at birth and during the early neonatal period, because reference values for this age group had not previously existed.² Preterm infants at different gestational ages showed distinct patterns, making gestational-age-specific reference ranges essential for accurate interpretation. A neonatal pregnenolone result that looks sky-high by adult standards could be perfectly normal for a baby born at 30 weeks.

This matters clinically because 3β-hydroxysteroid dehydrogenase deficiency, a form of congenital adrenal hyperplasia, needs to be caught early. In this condition, the enzyme that converts pregnenolone into the next hormone in the chain is missing or defective, so pregnenolone and 17-hydroxypregnenolone pile up. Without age-appropriate reference ranges, it is easy to either miss a true deficiency or falsely flag a healthy preterm infant.

Pregnenolone and Steroid Profiling for Adrenal Tumors

When an imaging scan picks up a mass on the adrenal gland, one of the first questions is whether it is benign or malignant. Adrenocortical carcinomas are rare but aggressive, and they tend to overproduce steroid precursors in patterns that benign tumors typically do not. A prospective cohort study found that a panel of steroid precursors, including 17-hydroxypregnenolone, was dramatically elevated in patients with adrenocortical carcinoma compared to those with benign masses. The difference was three- to tenfold, even when the analysis was limited to larger, more ambiguous-looking masses.³ In practice, a pregnenolone-family test is rarely used alone for this purpose; it is part of a multi-steroid panel that gives clinicians a biochemical fingerprint of the tumor’s activity.

Pregnenolone in Neuropsychiatric Research

Beyond the adrenal glands, pregnenolone has a separate life inside the brain. The brain can produce its own pregnenolone locally, and one of its main roles there is to serve as a precursor for neurosteroids. These neurosteroids influence brain receptors involved in learning, memory, and mood regulation.⁹ This has led researchers to look at whether blood pregnenolone levels differ between people with certain psychiatric conditions and healthy controls.

One study found that patients with schizophrenia had significantly lower serum pregnenolone levels and a shifted ratio of DHEA to pregnenolone compared to healthy subjects, and this pattern remained stable across multiple time points even after adjusting for age and sex.¹⁰ This does not mean a pregnenolone blood test can diagnose schizophrenia. But it does mean the test is being studied as a potential biomarker and as a way to monitor experimental neurosteroid-based treatments. Some clinical trials have given pregnenolone supplements to psychiatric patients and tracked blood levels to confirm the drug reached adequate concentrations.

Tracking Pregnenolone During Supplementation

Over-the-counter pregnenolone supplements are available in many countries, and some clinical trials have studied oral pregnenolone at various doses for conditions ranging from substance use disorders to mood disorders. A pilot study in individuals with cocaine use disorder found that both 300 mg and 500 mg daily doses of oral pregnenolone raised plasma pregnenolone significantly above placebo, and that the two doses achieved similar circulating levels. Importantly, levels remained fairly stable over the trial period at each dose.¹¹

If you are taking pregnenolone supplements on your own and then have a blood test, your results will obviously reflect that external supply rather than your body’s own production. This can confuse the clinical picture if your doctor is not aware of the supplement. Always disclose supplement use before any hormone testing. The test itself cannot distinguish between pregnenolone your adrenals made and pregnenolone you swallowed in a capsule.

How the Brain Makes Its Own Pregnenolone

A curious piece of the pregnenolone story is that the brain does not depend entirely on the adrenal glands for its supply. The brain contains enzymes that can synthesize pregnenolone from cholesterol locally. However, the dominant enzyme responsible for this appears to differ between species. A study comparing human, rat, and mouse brain tissue found that while rodent brains clearly produce the CYP11A1 enzyme (the same one the adrenal glands use), human brains showed no detectable CYP11A1 protein. Instead, a different enzyme called CYP1B1 appears to be the primary pregnenolone-synthesizing enzyme in the human brain.¹²

This is more than a trivia point. Much of what we know about neurosteroids comes from rodent research. If the human brain uses a different enzyme to make pregnenolone, findings from rat and mouse studies may not translate directly to people. It also means that drugs designed to boost or block brain pregnenolone synthesis might need to target a different enzyme in humans than the one studied in animal models. This species difference is an active area of investigation, and it adds a layer of caution to any claim about what brain pregnenolone “does” based on animal data alone.

Neurosteroid Therapies Already in the Clinic

While pregnenolone itself is still largely in the experimental phase for psychiatric use, one of its downstream products has already reached the clinic. Brexanolone, a synthetic form of allopregnanolone (which the body makes from pregnenolone via progesterone), was approved for the treatment of postpartum depression. It works by activating GABA-A receptors in the brain, rapidly relieving anxiety and mood symptoms.¹³ Brexanolone’s success has intensified interest in the broader neurosteroid pathway. Researchers are now asking whether measuring upstream precursors like pregnenolone could help predict who will respond to neurosteroid-based treatments, or whether low pregnenolone levels might identify patients whose neurosteroid production is impaired. The pregnenolone blood test, in this context, is being explored less as a diagnostic tool and more as a window into brain chemistry that is otherwise difficult to access without a spinal tap or brain biopsy.

Practical Tips If You Are Getting the Test

Given everything that can influence the result, a few practical steps help ensure your pregnenolone blood test gives the most meaningful information possible:

Schedule a morning draw: Pregnenolone’s circadian rhythm means morning levels are generally more consistent and reproducible.
Note your cycle day: If you menstruate, record the day of your cycle when the blood is drawn. Early follicular phase (roughly days two through five) provides the least hormonally “noisy” baseline.
Disclose supplements: Pregnenolone, DHEA, and progesterone supplements all feed into the same metabolic pathway and can distort the reading.
Ask about the assay method: If you have access to a lab that uses mass spectrometry for steroid panels, the result is likely to be more precise than one from an older immunoassay platform.
Mention shift work or unusual sleep patterns: Circadian disruption can lower pregnenolone, and your doctor needs that context to avoid misinterpreting a low result as adrenal disease.

Pregnenolone is a hormone that most people never think about unless something goes wrong. But its position at the top of the steroid production chain makes it a surprisingly informative marker when clinicians are trying to track down where a hormonal problem originates. As mass spectrometry becomes more widely available and neurosteroid research expands, the test is likely to be ordered more frequently and in a wider range of clinical settings than it is today.

1
Molecular and Cellular Endocrinology. Cholesterol side-chain cleavage, cytochrome P450, and the control of steroidogenesis
2
The Journal of Clinical Endocrinology & Metabolism. Longitudinal Study of Plasma Pregnenolone and 17-Hydroxypregnenolone in Full-Term and Preterm Neonates at Birth and during the Early Neonatal Period
3
The Journal of Clinical Endocrinology & Metabolism. Serum Steroid Profiling in the Diagnosis of Adrenocortical Carcinoma: A Prospective Cohort Study
4
PubMed. Studies on ovarian and adrenal steroids at different phases of the menstrual cycle: II. A comparative assessment of the circadian variation in steroid and lutropin levels during the follicular, periovulatory and luteal phases
5
PubMed. Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS/MS: Impact of gender, age, oral contraceptives, body mass index and blood pressure status
6
PubMed Central. Alterations in Pregnenolone and Testosterone Levels in Male Shift Workers
7
PubMed Central. Pre-analytical stability and physiological fluctuations affect plasma steroid hormone outcomes: A real-world study
8
PubMed. Preclinical challenges in steroid analysis of human samples
9
Current Opinion in Endocrine and Metabolic Research. Function, regulation, and pharmacological effects of pregnenolone in the central nervous system
10
European Neuropsychopharmacology. Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjects
11
PubMed Central. Stability and Reliability of Repeated Plasma Pregnenolone Levels After Oral Pregnenolone Dosing in Individuals with Cocaine Use Disorder: Pilot Findings
12
PubMed. Expression of pregnenolone-synthesizing enzymes CYP11A1 and CYP1B1 in the human, rat, and mouse brain
13
PubMed Central. Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy